Pharmaron Beijing Co Ltd (300759) — Free Cash Flow Generation Index
Pharmaron Beijing Co Ltd (300759) has a Free Cash Flow Generation Index of 0.28x as of September 2025. Free cash flow of CN¥290.95 Million represents 0% of operating cash flow (CN¥1.04 Billion). Explore 300759 capex to operating cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Pharmaron Beijing Co Ltd Free Cash Flow Generation Index (2014–2024)
Historical FCF Generation Index trend for Pharmaron Beijing Co Ltd across 11 annual periods. For the full cash flow conversion analysis, see 300759 cash flow conversion.
Annual Free Cash Flow Generation for Pharmaron Beijing Co Ltd (2014–2024)
Year-by-year Free Cash Flow Generation Index for Pharmaron Beijing Co Ltd. Check 300759 cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.21x | CN¥536.02 Million | CN¥2.58 Billion | CN¥2.04 Billion | ▲ +612.4% |
| 2023 | -0.04x | CN¥-111.78 Million | CN¥2.75 Billion | CN¥2.87 Billion | ▲ +89.2% |
| 2022 | -0.38x | CN¥-807.04 Million | CN¥2.14 Billion | CN¥2.95 Billion | ▼ -2128.8% |
| 2021 | -0.02x | CN¥-34.78 Million | CN¥2.06 Billion | CN¥2.09 Billion | ▼ -108.4% |
| 2020 | 0.20x | CN¥332.77 Million | CN¥1.65 Billion | CN¥1.32 Billion | ▲ +3.0% |
| 2019 | 0.20x | CN¥183.98 Million | CN¥938.59 Million | CN¥754.61 Million | ▲ +50.1% |
| 2018 | 0.13x | CN¥96.27 Million | CN¥737.26 Million | CN¥640.99 Million | ▲ +118.9% |
| 2017 | -0.69x | CN¥-382.45 Million | CN¥552.22 Million | CN¥934.67 Million | ▲ +80.1% |
| 2016 | -3.48x | CN¥-819.72 Million | CN¥235.77 Million | CN¥1.06 Billion | ▼ -1722.6% |
| 2015 | -0.19x | CN¥-41.38 Million | CN¥216.94 Million | CN¥258.32 Million | ▲ +96.7% |
| 2014 | -5.75x | CN¥-69.80 Million | CN¥12.13 Million | CN¥81.94 Million | — |